In the early phase of stroke, astrocytes can produce excess inflammatory cytokines, such as IL-1β or release glutamate and MMP-2 that causes degradation of matrix protein and subsequent blood-brain barrier (BBB) disruption, which eventually damages neuronal viability and causes encephaledema [92]. Here, IL1B is linked to stroke disorder.